Posted 2/28/2013 by hhill
This is big news. It is especially important news for women who have her2positive breast cancer. Feeling somewhat like a broken record, let me repeat the reality that much/most research is directed at finding targeted treatments that are effective for specific kinds of cancer cells. The discovery of herceptin changed the whole world of treatment for women with her2 positive breast cancers. What had been a particularly lethal form of the disease became one that was at least as treatable as any other. Many, many women have benefitted from herceptin and have been treated, gone on to stay strong and healthy without a breast cancer recurrence. The FDA announced this week that another drug to treat her2 positive disease, Kadcyla, has been approved.
Read more...